Nucala

Medicinal product

(Invented) name

Nucala

Active substance (s)

Mepolizumabas

Strength

100 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03DX09, Mepolizumab

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

2015-12-02

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for solution for injection	1 vnt.
Mepolizumabas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
64583	79067	1079067	flakonas	N1		Receptinis	EU/1/15/1043/001	Netiekiama	-	-	No	-	-
64584	79068	1079068	flakonas	N3x1		Receptinis	EU/1/15/1043/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-12-02	Registruotas